6-150865871-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015440.5(MTHFD1L):āc.49C>Gā(p.Gln17Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000247 in 1,212,672 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015440.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTHFD1L | NM_015440.5 | c.49C>G | p.Gln17Glu | missense_variant | 1/28 | ENST00000367321.8 | NP_056255.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MTHFD1L | ENST00000367321.8 | c.49C>G | p.Gln17Glu | missense_variant | 1/28 | 1 | NM_015440.5 | ENSP00000356290 | P4 | |
MTHFD1L | ENST00000367307.8 | c.49C>G | p.Gln17Glu | missense_variant | 1/8 | 1 | ENSP00000356276 | |||
MTHFD1L | ENST00000611279.4 | c.49C>G | p.Gln17Glu | missense_variant | 1/28 | 5 | ENSP00000478253 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000133 AC: 2AN: 150454Hom.: 0 Cov.: 32
GnomAD4 exome AF: 9.42e-7 AC: 1AN: 1062110Hom.: 0 Cov.: 31 AF XY: 0.00000196 AC XY: 1AN XY: 511472
GnomAD4 genome AF: 0.0000133 AC: 2AN: 150562Hom.: 0 Cov.: 32 AF XY: 0.0000136 AC XY: 1AN XY: 73522
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 22, 2023 | The c.49C>G (p.Q17E) alteration is located in exon 1 (coding exon 1) of the MTHFD1L gene. This alteration results from a C to G substitution at nucleotide position 49, causing the glutamine (Q) at amino acid position 17 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at